Rights:No known rights restrictions other than copyright.
Abstract:
Synthetic pathways leading to 4-(1-methyl-1,2-epoxypropyl)-1-oxaspiro[2,5]octane, 4-(1,5-dimethyl-1,2-epoxyhexyl)-1-oxaspiro-[2,5]octane and other compounds related to the antibiotic fumagillin have been investigated.